307 related articles for article (PubMed ID: 23965339)
21. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
[TBL] [Abstract][Full Text] [Related]
22. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy.
Takaoka T; Tomita N; Mizuno T; Hashimoto S; Tsuchiya T; Tomida M; Yanagi T
Technol Cancer Res Treat; 2021; 20():15330338211060170. PubMed ID: 34806489
[No Abstract] [Full Text] [Related]
24. Comparison of prostate proton treatment planning technique, interfraction robustness, and analysis of single-field treatment feasibility.
Kirk ML; Tang S; Zhai H; Vapiwala N; Deville C; James P; Bekelman JE; Christodouleas JP; Tochner Z; Both S
Pract Radiat Oncol; 2015; 5(2):99-105. PubMed ID: 25413411
[TBL] [Abstract][Full Text] [Related]
25. Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique.
Stoker JB; Grant J; Zhu XR; Pidikiti R; Mahajan A; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):637-44. PubMed ID: 25194667
[TBL] [Abstract][Full Text] [Related]
26. Benchmarking of a treatment planning system for spot scanning proton therapy: comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningioma.
Harding R; Trnková P; Weston SJ; Lilley J; Thompson CM; Short SC; Loughrey C; Cosgrove VP; Lomax AJ; Thwaites DI
Med Phys; 2014 Nov; 41(11):111710. PubMed ID: 25370624
[TBL] [Abstract][Full Text] [Related]
27. Partitioning of discrete proton arcs into interlaced subplans can bring proton arc advances to existing proton facilities.
Engwall E; Marthin O; Wase V; Sundström J; Mikhalev V; de Jong BA; Langendijk JA; Melbéus H; Andersson B; Korevaar EW; Both S; Bokrantz R; Glimelius L; Fredriksson A
Med Phys; 2023 Sep; 50(9):5723-5733. PubMed ID: 37482909
[TBL] [Abstract][Full Text] [Related]
28. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
29. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric impact of systematic spot position errors in spot scanning proton therapy of head and neck tumor.
Yasui K; Omi Y; Shimomura A; Muramatsu R; Iwata H; Ogino H; Hayashi N
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147973
[TBL] [Abstract][Full Text] [Related]
31. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
[No Abstract] [Full Text] [Related]
32. Robust beam orientation optimization for intensity-modulated proton therapy.
Gu W; Neph R; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2019 Aug; 46(8):3356-3370. PubMed ID: 31169917
[TBL] [Abstract][Full Text] [Related]
33. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
Br J Radiol; 2020 Mar; 93(1107):20190573. PubMed ID: 31778315
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
35. Robust optimization of intensity modulated proton therapy.
Liu W; Zhang X; Li Y; Mohan R
Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
[TBL] [Abstract][Full Text] [Related]
36. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
38. Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques.
Wei S; Lin H; Isabelle Choi J; Shi C; Simone CB; Kang M
Radiother Oncol; 2022 Oct; 175():238-247. PubMed ID: 35961583
[TBL] [Abstract][Full Text] [Related]
39. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
40. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]